000 | 01469 a2200373 4500 | ||
---|---|---|---|
005 | 20250516230231.0 | ||
264 | 0 | _c20160222 | |
008 | 201602s 0 0 eng d | ||
022 | _a0065-7778 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAnderson, Mark E | |
245 | 0 | 0 |
_aThree ways to die suddenly: do they all require calcium calmodulin-dependent protein kinase II? _h[electronic resource] |
260 |
_bTransactions of the American Clinical and Climatological Association _c2014 |
||
300 |
_a173-85 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
650 | 0 | 4 |
_aArrhythmias, Cardiac _xdrug therapy |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aDeath, Sudden, Cardiac _xetiology |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 | _aHeart Rate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aMyocardium _xenzymology |
650 | 0 | 4 | _aOxidative Stress |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 | _aRenin-Angiotensin System |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
773 | 0 |
_tTransactions of the American Clinical and Climatological Association _gvol. 125 _gp. 173-85 |
|
999 |
_c24100494 _d24100494 |